North East and North Cumbria
ICS Formulary
ICS Formulary
4 Central nervous system
04-03-03 Selective serotonin re-uptake inhibitors
| Fluoxetine |
|
First Choice
|
|
 MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery |
|
| Paroxetine |
|
First Choice
|
|
MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery |
|
|
| Sertraline |
|
First Choice
|
|
|
MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery |
|
|
Links
- MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs
- MHRA Drug Safety Update (Dec 2014): Citalopram and escitalopram: QT interval prolongation
- MHRA Drug Safety Update (Dec 2014): Citalopram and escitalopram: QT interval prolongation
- MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- MHRA Drug Safety Update (Jan 2021): SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- MHRA Drug Safety Update (July 2016): Citalopram: suspected drug interaction with cocaine; prescribers should consider enquiring about illicit drug use
NENC Palliative and End of Life Care Symptom Control Guidelines- NICE CG192: Antenatal and postnatal mental health
- NICE CG31: Obsessive-compulsive disorder
- NICE CG91: Depression in adults with a chronic physical health problem: recognition and management
- NICE NG116: Post-traumatic stress disorder
- NICE NG134: Depression in children and young people: identification and management
- NICE NG206: Chronic fatigue syndrome / Myalgic encephalomyelitis
- NICE NG222: Depression in adults: treatment and management
- NICE NG62: Cerebral palsy in under 25s: assessment and management
- NICE TA367 - Vortioxetine for treating major depressive episodes
- TEWV - Medicines Optimisation – Interactive Guide
- TEWV Depression medication pathway for adults
- TEWV Guidelines
- TEWV Safe Transfer of Prescribing Guidance